跳至主要内容
临床试验/NCT04668781
NCT04668781已完成不适用

Improvement of Care of Patients Undergoing Pancreaticoduodenectomy

Helsinki University Central Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年12月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
The norepinephrine consumption

研究概览

简要总结

The study is a randomised controlled trial comparing the effectivity and impact of epidural analgesia and wound catheter analgesia in patients undergoing pancreaticoduodenectomy. The aim of the study is to examine whether there are a difference in perioperative fluid therapy and complication rates between the patients in epidural and wound catheter groups.

详细描述

All patients undergoing pancreaticoduodenectomy in Helsinki University Hospital are recruited in the study. Patients meeting the inclusion criteria and giving consent to participate the study will be randomised to whether epidural analgesia group or wound catheter analgesia group. Both groups receive additional analgesia with intravenous PCA-oxycodone (patient controlled analgesia).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18 years or over
  • patients who undergo pancreaticoduodenectomy

排除标准

  • patients to whom are made a major vascular reconstruction
  • patients with significant comorbidities and inability to use PCA
  • regural use of strong opioids or drugs preoperatively
  • patients with severe chronic pain issues
  • chronic atrial fibrillation
  • patients who refuse to take part to the study

研究组 & 干预措施

Epidural analgesia

Active Comparator

干预措施: Analgesia via epidural catheter (Procedure)

Wound catheter analgesia

Experimental

干预措施: Analgesia via wound catheter (Procedure)

结局指标

主要结局

The norepinephrine consumption

时间窗: Postoperative day 0

Norepinephrine consumption on POD 0

次要结局

  • Fluid volumes on PODs 0-4(Postoperative days 0-4)
  • Oxycodone consumption(Postoperative days 1-4)
  • Hospital length of stay(Postoperative days 0-60)
  • Postoperative complications(Postoperative days 0-90)
  • Reoperation rates(Postoperative days 0-90)
  • Readmission rates(Postoperative days 0-90)
  • Mortality(postoperative day 0-90)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Piia Peltoniemi

M.D., Principal Investigator

Helsinki University Central Hospital

研究点 (2)

Loading locations...

相似试验

Improvement of Care of Patients Undergoing... | 临床试验